Key Facts
- CAS
- 53714-56-0
- Molecular Weight (MW)
- 1209.4 g/mol (free base); 1269.4 g/mol (acetate)
- Half-life
- ~3 hours (immediate-release); depot provides sustained levels
- Unit
- mcg
- Administration Route
- Subcutaneous / Intramuscular
- Frequency
- Daily, monthly, every 3 months, or every 4 months depending on formulation
- Last updated
- 12/14/2025
Overview
—
Protocol
- Dosage Range
- Varies by indication: 1 mg daily, 7.5 mg monthly, 22.5 mg every 3 months, or 30 mg every 4 months
- Frequency
- Daily, monthly, every 3 months, or every 4 months depending on formulation
- Cycle
- Long-term use as prescribed
- Administration Route
- Subcutaneous / Intramuscular
- Reconstitution Guide
- Depot formulations require reconstitution per package insert
May vary by vendor concentration and protocol.
Science
Mechanism of Action
Mechanism of action not fully established in publicly available sources.
Studies are being curated for this entry.
Suggest a studyBenefits
Therapeutic benefits not fully established.
Potential Side Effects
- Side effects not fully established.
References
- FDA Label - LupronExternal link · Year —